EA201492238A1 - Композиция мизопростола - Google Patents

Композиция мизопростола

Info

Publication number
EA201492238A1
EA201492238A1 EA201492238A EA201492238A EA201492238A1 EA 201492238 A1 EA201492238 A1 EA 201492238A1 EA 201492238 A EA201492238 A EA 201492238A EA 201492238 A EA201492238 A EA 201492238A EA 201492238 A1 EA201492238 A1 EA 201492238A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mizoprostol
composition
misoprostol
methods
compositions
Prior art date
Application number
EA201492238A
Other languages
English (en)
Other versions
EA031594B1 (ru
Inventor
Барбара Л. Пауэрс
Стивен Робертсон
Original Assignee
Ферринг Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12178079.5A external-priority patent/EP2689781A1/en
Priority claimed from EP13150702.2A external-priority patent/EP2754442A1/en
Application filed by Ферринг Б.В. filed Critical Ферринг Б.В.
Publication of EA201492238A1 publication Critical patent/EA201492238A1/ru
Publication of EA031594B1 publication Critical patent/EA031594B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к применению мизопростола для возбуждения родовой деятельности у беременной женщины и, в частности, к применению устройства замедленной доставки или вкладыша, содержащего, по существу, 200 мкг мизопростола, для внутривлагалищного применения. Применение охватывает способы лечения, а также композиции для применения в таких способах.
EA201492238A 2012-07-26 2013-07-25 Способ уменьшения дородового применения окситоцина и применение внутривлагалищного вкладыша по указанному назначению EA031594B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12178079.5A EP2689781A1 (en) 2012-07-26 2012-07-26 Misoprostol composition
EP13150702.2A EP2754442A1 (en) 2013-01-09 2013-01-09 Misoprostol for the induction of labour
PCT/EP2013/065767 WO2014016394A1 (en) 2012-07-26 2013-07-25 Misprostol composition

Publications (2)

Publication Number Publication Date
EA201492238A1 true EA201492238A1 (ru) 2015-06-30
EA031594B1 EA031594B1 (ru) 2019-01-31

Family

ID=48856654

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492238A EA031594B1 (ru) 2012-07-26 2013-07-25 Способ уменьшения дородового применения окситоцина и применение внутривлагалищного вкладыша по указанному назначению

Country Status (12)

Country Link
US (2) US20150174139A1 (ru)
EP (1) EP2877181A1 (ru)
JP (2) JP2015522646A (ru)
KR (1) KR20150038174A (ru)
CN (1) CN104507482A (ru)
AU (2) AU2013294960B2 (ru)
CA (1) CA2879772A1 (ru)
EA (1) EA031594B1 (ru)
HK (1) HK1210966A1 (ru)
IL (1) IL236357A0 (ru)
MX (1) MX2015001007A (ru)
WO (1) WO2014016394A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
PL2965750T3 (pl) 2014-07-11 2018-01-31 Azanta Danmark As Dyspergowalna tabletka z mizoprostolem
TN2017000003A1 (en) 2014-07-11 2018-07-04 Azanta Danmark As Misoprostol dispersible tablet.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU537741B2 (en) 1979-03-21 1984-07-12 British Technology Group Limited Controlled release compositions
US20040044080A1 (en) 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
US20020013304A1 (en) 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
AU752294B2 (en) 1998-12-30 2002-09-12 Quest International Services B.V. Diacetyl tartaric acid esters of mono- and diglycerides based on C12 to C22 fatty acids
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7263335B2 (en) * 2004-07-19 2007-08-28 Purewave Networks, Inc. Multi-connection, non-simultaneous frequency diversity in radio communication systems
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
NZ604064A (en) * 2010-06-11 2014-10-31 Ferring Bv Intravaginal administration of misoprostol

Also Published As

Publication number Publication date
CN104507482A (zh) 2015-04-08
AU2018206847A1 (en) 2018-08-09
MX2015001007A (es) 2015-04-09
CA2879772A1 (en) 2014-01-30
JP2018184413A (ja) 2018-11-22
KR20150038174A (ko) 2015-04-08
JP2015522646A (ja) 2015-08-06
EP2877181A1 (en) 2015-06-03
AU2013294960A1 (en) 2015-01-22
HK1210966A1 (en) 2016-05-13
US20170112854A1 (en) 2017-04-27
AU2013294960B2 (en) 2018-04-19
EA031594B1 (ru) 2019-01-31
US20150174139A1 (en) 2015-06-25
WO2014016394A1 (en) 2014-01-30
IL236357A0 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
EA201591591A1 (ru) Соединения карбазола, применяемые в качестве ингибиторов бромодомена
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
IN2014DN10386A (ru)
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
NZ700928A (en) Dna-pk inhibitors
GB201118656D0 (en) New compounds
MX2013004061A (es) Analogos de ciclosporina.
MX2016007625A (es) Composiciones de liberacion retardada de linaclotida.
MX2016004556A (es) Composicion de hueso comprimido y metodo para usar la misma.
EA201590491A1 (ru) Иммуногенная композиция
EA201500851A1 (ru) ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3)
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
MX2013004062A (es) Analogos de ciclosporina.
PH12015502405B1 (en) Methods and compositions for wound healing
PH12016500495A1 (en) Compositions for the treatment of hypertension and/or fibrosis
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
EA201492238A1 (ru) Композиция мизопростола
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
MX2016002714A (es) Composicion y metodo para tropicalizar chocolate.
MX2022002614A (es) El uso de un pesario que comprende una capsula que contiene estradiol y un agente solubilizante para el tratamiento de la atrofia vulvovaginal.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU